Librela
Pajjiż: Unjoni Ewropea
Lingwa: Iżlandiż
Sors: EMA (European Medicines Agency)
Fuljett ta 'informazzjoni
(PIL)
31-05-2024
Karatteristiċi tal-prodott
(SPC)
31-05-2024
Rapport ta 'Valutazzjoni Pubblika
(PAR)
31-05-2024
Ingredjent attiv:
bedinvetmab
Disponibbli minn:
Zoetis Belgium
Kodiċi ATC:
QN02B
INN (Isem Internazzjonali):
bedinvetmab
Grupp terapewtiku:
Hundar
Żona terapewtika:
Verkjalyf
Indikazzjonijiet terapewtiċi:
For the alleviation of pain associated with osteoarthritis in dogs.
Sommarju tal-prodott:
Revision: 1
L-istatus ta 'awtorizzazzjoni:
Leyfilegt
Data ta 'l-awtorizzazzjoni:
2020-11-10
Fuljett ta 'informazzjoni
OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Nýjustu upplýsingar um þetta dýralyf er að finna á
upplýsingasíðu dýralyfja.
Aqra d-dokument sħiħ
Karatteristiċi tal-prodott
OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Nýjustu upplýsingar um þetta dýralyf er að finna á
upplýsingasíðu dýralyfja.
Aqra d-dokument sħiħ
